Browse all clinical trials

Sponsor Updatedsort icon
Phase III Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer National Cancer Institute (NCI) 2009-05-20
Phase I Ixabepilone in Combination With Carboplatin in Patients With Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb 2009-05-20
Phase III Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers Novartis 2009-05-20
Phase I Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma Bristol-Myers Squibb 2009-05-20
Phase I Study of BMS-663513 in Patients With Advanced Cancer Bristol-Myers Squibb 2009-05-20
Phase II Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase III Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma National Cancer Institute (NCI) 2009-05-20
Phase III Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. Pfizer 2009-05-20
Phase II Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide National Cancer Institute (NCI) 2009-05-20
Phase III Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury National Institute of Neurological Disorders and Stroke (NINDS) 2009-05-20
Phase I Phase I Combination w/ Epirubicin Bristol-Myers Squibb 2009-05-20
Phase III Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Bristol-Myers Squibb 2009-05-20
Phase III Comparison of 4.0 mg/kg Sugammadex at 1-2 PTC in Renal or Control Patients (19.4.328) Organon 2009-05-20
Phase III Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4) Novartis 2009-05-20
Phase II PoC in Rheumatoid Arthritis With Methotrexate Bristol-Myers Squibb 2009-05-20
Phase II Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer National Cancer Institute (NCI) 2009-05-20
Effects of a Low Glycemic Load Diet on Fatty Liver in Children Children's Hospital Boston 2009-05-20
Phase IV A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. Pfizer 2009-05-20
Phase II Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia National Cancer Institute (NCI) 2009-05-20
Phase I Dasatinib in Combination With Revlimid (and Dexamethasone) Bristol-Myers Squibb 2009-05-20
Aerobic Exercise in Patients Receiving Chemotherapy for Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Bristol-Myers Squibb 2009-05-20
Phase III The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) Shaheed Beheshti Medical University 2009-05-20
Phase III Study of Dasatinib in Patients With Chronic Phase CML and a Suboptimal Response to Imatinib Bristol-Myers Squibb 2009-05-20